CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 110.00
+4.50 (4.27%)
At close: Oct 23, 2025
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 11.31 billion as of October 24, 2025. Its market cap has increased by 47.85% in one year.
Market Cap
11.31B
Enterprise Value
11.57B
Revenue
1.68B
Ranking
n/a
PE Ratio
31.18
Stock Price
110.00
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 11.31B, an increase of 51.38%. That is a compound annual growth rate of 4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 11.31B | 36.14% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | 4.26B | -25.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 335.87B |
| China Steel | 286.54B |
| Formosa Plastics | 247.95B |
| Formosa Chemicals & Fibre | 176.64B |
| TCC Group Holdings | 172.84B |
| Walsin Lihwa | 133.83B |
| Asia Cement | 132.46B |
| Ta Chen Stainless Pipe | 81.79B |